Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

This current review explores selected and as yet insufficiently investigated frontiers in
current alopecia areata (AA) pathobiology research, with an emphasis on potential “new” …

The advancement of genetic and preclinical studies has uncovered the mechanisms
involved in the pathogenesis of alopecia areata (AA). The development of targeted therapies …

The ability to manipulate the mammalian hair cycle will lead to novel therapies and
strategies to combat all forms of alopecia. Thus, in addition to the epithelial‐mesenchymal …

Cytotoxic T lymphocyte has been a concern for the etiopathogenesis of alopecia areata
(AA), some recent evidence suggests that the regulatory T (Treg) cell deficiency is also a …

Introduction Alopecia areata (AA) is a non-scarring, hair loss disorder and a common
autoimmune-mediated disease with an estimated lifetime risk of about 2%. To date, the …

Hair is a biofilament with unique multi-dimensional values. In human, in addition to
physiologic impacts, hair loss and hair related disorders can affect characteristic features …

Background Alopecia areata (AA) is a chronic inflammatory disease that affects the hair
follicles and sometimes the nails. It usually presents as a single or multiple patches of hair …

The term “alopecia” is used for abnormal hair loss and it is a chronic dermatological
condition observed in both genders and all races. Androgenetic alopecia (AGA) or male …

Alopecia areata (AA) is an immune-mediated disorder characterized by nonscarring hair
loss on the scalp or any hair-bearing surface, varying from small well-defined patches to the …